EGFR and gastric cancer: Our previous study demonstrates that CMTM3 suppresses metastasis of gastric cancer through the STAT3/EMT signaling pathway by interacting with Rab5 to facilitate EGFR degradation [31, 32] and CMTM3 may serve as a prognostic and predictive biomarker in gastric cancer [33].